Invivyd (IVVD) CMO reports 375,000 stock options vesting over 4 years
Rhea-AI Filing Summary
Invivyd, Inc. reports that CMO and Chief Epidemiologist Mina Michael beneficially holds a stock option to purchase 375,000 shares of common stock at an exercise price of $1.33 per share, expiring on March 31, 2036. The option vests over four years, with 25% vesting on March 5, 2027 and the remaining 75% vesting in substantially equal monthly installments over the following three years, subject to continuous service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Mina Michael
Role
CMO and Chief Epidemiologist
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 375,000 shares (Direct)
Footnotes (1)
- F1. This option vests over a four-year period, with 25% of the shares subject to the option vesting on March 5, 2027, and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.
Key Figures
Stock option underlying shares: 375,000 shares
Exercise price: $1.3300 per share
Option expiration date: 2036-03-31
+2 more
5 metrics
Stock option underlying shares
375,000 shares
Underlying Invivyd common shares for stock option held by Mina Michael
Exercise price
$1.3300 per share
Exercise price of Mina Michael’s stock option
Option expiration date
2036-03-31
Expiration date of the reported stock option
Initial vesting date
March 5, 2027
25% of the option shares vest on this date
Vesting period
4 years
Option vests over four years, with remaining 75% in monthly installments
Key Terms
Stock Option (Right to Buy), underlying security, vesting, continuous service
4 terms
Stock Option (Right to Buy) financial
"Security title reported as "Stock Option (Right to Buy)" for Mina Michael."
underlying security financial
"The underlying security title is reported as common stock, the underlying security."
vesting financial
"This option vests over a four-year period, with 25% of the shares vesting on March 5, 2027."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"Vesting is subject to the Reporting Person's continuous service as of each vesting date."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity position did Invivyd (IVVD) disclose for CMO Mina Michael?
Invivyd disclosed that CMO and Chief Epidemiologist Mina Michael holds a stock option over 375,000 common shares. The option has a $1.33 exercise price, a March 31, 2036 expiration, and vests over four years, subject to continued service.
What is the vesting schedule for Mina Michael’s Invivyd (IVVD) stock option?
The option vests over four years, with 25% of the shares vesting on March 5, 2027. The remaining 75% vest in substantially equal monthly installments over the next three years at a rate of 1/48th per month, subject to continuous service.
What are the exercise price and expiration date of Mina Michael’s Invivyd (IVVD) option?
The stock option has an exercise price of $1.33 per share and expires on March 31, 2036. This gives a long-dated right to purchase Invivyd common shares once the option is vested and subject to any applicable exercise conditions.
Is Mina Michael’s Invivyd (IVVD) stock option held directly or indirectly?
The option is reported as held directly by Mina Michael. The ownership code is “D”, indicating direct beneficial ownership of the stock option position covering 375,000 underlying Invivyd common shares.